About This Publication:

  • Print This Page
  • Text a Friend
  • Subscribe to an RSS Feed

Sample Content 

My Liebert Connect

Sign up to stay informed--receive email notifications for this journal

Journal of Aerosol Medicine
and Pulmonary Drug Delivery

Editor-in-Chief: Gerald C. Smaldone, MD, PhD

ISSN: 1941-2711 • Published Bimonthly • Online ISSN: 1941-2703

Current Volume: 27

Latest Impact Factor* is 2.395

*2013 Journal Citation Reports® published by Thomson Reuters, 2014

For Authors

  • Manuscript Submissions
  • NIH/HHMI Wellcome Trust Policies
  • Self-Archiving Policy
  • Open Access Policy
  • Manuscript Submissions

    The Official Journal of the International Society for Aerosols in Medicine

    Instructions for Authors

    Manuscripts MUST be submitted online (only Word docs, not PDF) using the following URL: http://mc.manuscriptcentral.com/aerosol

    PAGE CHARGES. To help defray the cost of printing, the Publisher requests that page charges, currently $45 USD per printed page, be paid by all authors who have funds available from research grants or from their institutions. Members of ISAM (the International Society for Aerosols in Medicine) are requested to pay a reduced rate of $20 USD per printed page. Payment of page charges is not a prerequisite for publication of any paper.

    Manuscript Submission

    Authorship. All authors, including the co-authors, should be responsible for a significant part of the manuscript.  All authors and co-authors should have taken part in writing the manuscript, reviewing it, and revising its intellectual and technical content.   Any author whose name appears on a paper assumes responsibility and accountability for the results.

    TITLE PAGE.  The title page should include the full title of the manuscript, all contributing authors’ names, academic degrees and affiliations, the source of a work or study (if any), and a running title of no more than 50 characters (including spaces). Indicate clearly the author to whom correspondence should be sent.
    ABSTRACT. For all original papers, the next page of the manuscript should consist of a structured abstract of no more than 300 words, which should be self-explanatory without reference to the text. The structured abstract should consist of:   Background, Methods, Results and Conclusions.  Abstracts for review papers, letters to the editor and responses may be unstructured.  References are not permitted in the abstract.

    KEY WORDS. Please provide a minimum of four key words below the abstract.

    TEXT. The text of the manuscript should follow this format: Abstract; Introduction; Materials and Methods; Results; Discussion; Acknowledgments; Author Disclosure Statement; and References. Number pages consecutively. All manuscripts should be double-spaced, with a one-inch margin on all sides. For all material sources, such as devices, drugs, etc., indicate manufacturer/supplier name, city, state, and country.  At the end of the manuscript, give the name and full address of the individual to whom correspondence should be directed.

    TABLES. Prepare tables double-spaced, one to a page and placed after the Reference section. Each table must stand alone, i.e., contain all necessary information in the table title and be understood independently of the text. Avoid repetition of information that is given in the text. Supply each table with a title.

    FIGURES and LEGENDS. Figures must be submitted separately using the following guidelines:


    • When appropriate line drawings instead of photographs should be used.
    • Each figure should be numbered, and reducible to 60% with labels still readable.  Do not include the legend on the figure.
    • Figure legends must be prepared as an enumerated list on a separate page after the reference section.
    • Do not include any illustrations as part of your text file.
    • Do not prepare any figures in Word, as they are not workable.
    •  Line illustrations must be submitted at 900 DPI.
    • Halftones and color photos should be submitted at a minimum of 300 DPI.
    • Adobe is the preferred software. Save figures as either TIFF or EPS files.
    •  Color figures* must be saved as CYMK, not RGB.

    *The Journal will publish color figures, but the author must subsidize the cost. The Publisher will provide the author with a cost estimate when the figures are received if requested. Submissions with color figures will not be reviewed unless authors specifically state at the time of manuscript submission that they agree to pay the cost of color publication.

    FOOTNOTES.  Type footnotes double-spaced on a separate page. The use of footnotes is generally discouraged, but can used only when essential.

    ACKNOWLEDGMENTS. Collaborations, sources of research funds, and other acknowledgments should be listed in a separate section at the end of the text ahead of the References section.

    AUTHOR DISCLOSURE STATEMENT.  Immediately following the Acknowledgments section, there should be a header entitled, “Author Disclosure Statement.” All authors are expected to disclose any institutional or commercial affiliations that might pose a conflict of interest regarding the publication of a manuscript.  Institutional affiliations, as indicated on the title page, should include all corporate affiliations and any funding sources that support the work. Other types of affiliation, including consultancies, honoraria, stock ownership, equity interests, arrangements regarding patents, or other vested interests should also be disclosed in the Disclosure section.  If there are no conflicts to declare, the authors must state, “No conflicts of interest exist.”

    REFERENCES.  Follow Endnote style  “J Aerosol Medicine.ens”


    • All references must be cited in the text with superscript numbers, in numerical order, beginning with “1.” References must be typed double-spaced and numbered by order of citation. 
    • ALL AUTHORS’ NAMES OF CITED WORKS MUST BE LISTED (do NOT use “et al.”). Translate into English all foreign article and book titles.
    • If a work is in press, give the journal in which it is to be published, followed by “in press” in parentheses.
    •  Submitted manuscripts not yet accepted for publication and personal communications should be cited in the text only.
    • Journal abbreviations should follow Medline style (see www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed).


    JOURNAL ARTICLES: 1. Newman SP, Pitcairn GR, Hooper G, Knoch M: Efficient drug delivery to the lungs from a continuously open-vent nebulizer and low-pressure compressor system. Eur Respir J 1994;7:1177–1181.

    BOOKS: Johari D: Scanning Electron Microscopy: Workshop on Advances in Medical Applications of the SEM, STEM. Chicago Press Corp., Chicago, IL; pp. 720–727, 1977.

    CHAPTERS IN BOOKS: Jaegfeldt H, Andersson JAR, Trofast E, Wetterlin KIL: Particle size distribution from different modifications of Turbuhaler. In: SP Newman,
    F Moren, and GK Crompton, (eds). A New Concept in Inhalation Therapy. Medicom, Bussum; pp. 90–98, 1987.

    MEETING ABSTRACTS: Darquenne C, Oakes JM, Breen EC, Scadeng M: Quantification of aerosol deposition in healthy and emphysematous rat lung using MRI. [Abstract]. Presented at the International Society for Aerosols in Medicine Congress, Rotterdam, The Netherlands, June 18–22, 2011; J Aerosol Med. 24:3;A1–A66; DOI: 10.1089/jamp.2011.00A1 (online only).

    Before uploading your final manuscript, please make sure the manuscript is completely clean with no track changes embedded.

    REVISIONS. If your article is a REVISION please make certain what you have uploaded reflects the following 3 items:


     1.   EACH REVISION must be submitted with the corrected document (only Word docs, not PDFs) showing visible track changes as well as a ‘clean’ document ‘publication ready’ (without track changes) should it be accepted.

    2.   EACH REVISION should be COMPLETE with title page, author contact information, abstract, references, etc.

    3.   ALL figures and tables are to be uploaded with EACH REVISION.

    Copyright Agreement Form

    PERMISSIONS. The author must obtain permission whenever it is required in conjunction with the reproduction of material such as figures and tables from copyrighted material. Written permission must be obtained from the publisher (not the author or editor) of the journal or book concerned. The publication from which the figure or table is taken must be listed in the reference list. Finally, the first footnote of a reprinted table, or the last sentence of the legend of a reprinted figure, should read “Reprinted by permission from Ref. 00.” and list appropriate reference number. All permission listings must be shown on the manuscript.


    Once a paper is accepted, changes in authorship in page proofs are NOT permitted under any circumstance.

    It is the Journal’s policy that a manuscript has only ONE corresponding author listed on a paper.  This designation should be determined at the time of submission.  Additions to corresponding authors are not permitted after acceptance or in page proofs.  It is the corresponding author’s responsibility to share the page proofs with co-authors and to coordinate all authors’ corrections into one proof.  The Publisher will not accept corrections from multiple authors.

    REPRINTS. Reprints may be ordered by following the special instructions that will accompany page proofs, and should be ordered at the time the corresponding author returns the corrected page proofs to the Publisher. Reprints ordered after an issue is printed will be charged at a substantially higher rate.

    PUBLISHER. The Journal is published bimonthly by Mary Ann Liebert, Inc., 140 Huguenot Street, New Rochelle, NY 10801-5215. Telephone:  914-740-2100; Fax:  914-740-2108; Email: info@liebertpub.com;  Online: www.liebertpub.com/jamp

  • NIH/HHMI Wellcome Trust Policies

    NIH Public Access Policy: In order to assist our authors who have NIH funding to comply with this policy, Mary Ann Liebert, Inc. publishers will deposit the final accepted paper (after copy-editing and proofreading) to PubMed Central (PMC) on behalf of the authors. Authors need not take any action. The manuscript's public access posting on PMC will occur 12 months after final publication. This service is provided free of charge. Please note that authors may not deposit manuscripts directly to PMC or other sites without permission from Mary Ann Liebert, Inc.

  • Self-Archiving Policy

    Mary Ann Liebert, Inc. is a "blue" publisher (as defined by Sherpa), as we allow self-archiving of post-print (ie final draft post-refereeing) or publisher's version/PDF.

    In assigning Mary Ann Liebert, Inc. copyright, the author retains the right to deposit such a 'post-print' on their own website, or on their institution's intranet, or within the Institutional Repository of their institution or company of employment, on the following condition, and with the following acknowledgement:

    This is a copy of an article published in the [JOURNAL TITLE] © [year of publication] [copyright Mary Ann Liebert, Inc.]; [JOURNAL TITLE] is available online at: http://online.liebertpub.com.

    Authors may also deposit this version on his/her funder's or funder's designated repository at the funder's request or as a result of a legal obligation, provided it is not made publicly available until 12 months after official publication.

  • Open Access Policy

    Choose Liebert Open Access Option!

    Ensure maximum visibility, discoverability, and impact for your article with our Liebert Open Access (OA) Option.

    Your investment guarantees:

    • Immediate, unrestricted global access in 170 countries
    • Maximum visibility for increased readers, citations, and downloads
    • Targeted email announcement highlighting your article to thousands of thought-leaders in your field
    • Rapid, rigorous peer-review and editorial attention
    • Fast Track online-ahead-of-print publication
    • Immediate upload to PubMed Central and other internationally recognized repositories*
    • Recognition on online Table of Contents with exclusive OA icon
    • Compliance with OA funding mandates with no embargo period
    • Savings on future OA article publication
    • Complimentary membership in AuthorCite®, the author services platform exclusively licensed by Mary Ann Liebert, Inc. that delivers the tools you need to maximize your professional impact.

    These valuable benefits are included with a one-time article processing charge (APC). APC charge varies based on journal, membership, and subsequent submissions.

    Contact openaccess@liebertpub.com for questions on article Open Access options. 

     *Please note that PubMedCentral, not the Publisher, has sole control over when the paper is made live on PMC.


    Is your Institution a member of the Liebert Author Advocacy Program?

    The Liebert Author Advocacy Program (LAAP) provides valuable membership benefits for OA publication to institutional and funding organizations, and supports global funding mandates.  Authors who are affiliated with LAAP member institutions receive all the valuable benefits of Liebert OA article publication, and more.

    For details, and to recommend institutional membership visit: www.authoradvocacy.com or contact laap@liebertpub.com 




The views, opinions, findings, conclusions and recommendations set forth in any Journal article are solely those of the authors of those articles and do not necessarily reflect the views, policy or position of the Journal, its Publisher, its editorial staff or any affiliated Societies and should not be attributed to any of them.

Recommended Publications

You may be interested in the following publications:

    Pediatric Allergy, Immunology, and Pulmonology

    Pediatric Allergy, Immunology, and Pulmonology

    Original, clinical epidemiologic research on the most common chronic illnesses of children—asthma and allergies—as well as many less common and rare diseases.

    High Altitude Medicine & Biology

    High Altitude Medicine & Biology

    The first peer-reviewed journal focused exclusively on the latest advances in high altitude life sciences, and is the primary source of information for clinicians and researchers studying its physiological effect on the body.

    Microbial Drug Resistance

    Microbial Drug Resistance

    The international peer-reviewed journal covering the global spread and threat of multi-drug resistant clones of major pathogens that are widely documented in hospitals and the scientific community.

    Diabetes Technology & Therapeutics

    Diabetes Technology & Therapeutics

    The only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes.

Browse All Publications »